Locally advanced transverse colon cancer with Trousseau’s syndrome
https://doi.org/10.17650/2220-3478-2012-0-2-53-57
Abstract
Migratory venous thrombosis is a manifestation of the rare paraneoplastic syndrome in patients with malignant neoplasms. The paper describes successful surgical treatment in a young patient with a colon tumor associated with Trousseau’s syndrome. The latter manifesting itself as ischemia forced urgent surgeons to amputate the lower third of the left leg. Locally advanced transverse colon cancer spreading to the great vessels was subsequently diagnosed. All paraneoplastic manifestations disappeared after tumor removal. The patient was professionally given surgical, anesthesiological, and resuscitative aids that not only improved his quality of life, but also gave the chance to prolong it.
About the Authors
V. A. Aliyev
Research Institute of Clinical Oncology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Department of Proctology
Russian Federation
Department of Proctology
M. G. Abgaryan
Research Institute of Clinical Oncology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Department of Proctology
Russian Federation
Department of Proctology
D. V. Kuzmichev
Research Institute of Clinical Oncology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Department of Proctology
Russian Federation
Department of Proctology
A. O. Atroshchenko
Moscow State University of Medicine and Dentistry
Russian Federation
Faculty Surgery Department Two
Russian Federation
Faculty Surgery Department Two
N. A. Kochura
Research Institute of Clinical Oncology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Department of Proctology
Russian Federation
Department of Proctology
I. Sh. Tatayev
Research Institute of Clinical Oncology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Department of Proctology
Russian Federation
Department of Proctology
A. I. Ovchinnikova
Research Institute of Clinical Oncology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Department of Proctology
Russian Federation
Department of Proctology
A. V. Polynovsky
Research Institute of Clinical Oncology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Department of Proctology
Russian Federation
Department of Proctology
References
1. Hobbs C.B., Miller A.L. Review of endocrine syndromes associated with tumours of non-endocrine origin. J Clin Pathol 1966 Mar;19(2):119−27.
2. Cabanne F., Fayolle J., Guichard A. et al. Polyneuritis in cancer patients and neoplastic
3. polyneuritis; three case reports. Lyon Med 1956 Oct 7;88(41):309−29.
4. Trousseau A. Phlegmasia alba dolens. Clin Med Hotel Dieu de Paris 1865;3:94.
5. Sack G.H., Levin J., Bell W.R. Trousseau’s syndrome and other manifestations
6. of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features. Medicine (Baltimore) 1977;56:1−37.
7. Batsis J.A., Morgenthaler T.I. Trousseau syndrome and the unknown cancer: use of positron emission tomographic imaging in a patient with a paraneoplastic syndrome. Mayo Clin Proc 2005 Apr;80(4):537−40.
8. Abildgaard U., Lindahl A.K., Sandset P.M. Heparin requires both antithrombin and extrinsic pathway inhibitor for its anticoagulant effect in human blood. Haemostasis 1991; 21:254−7.
9. Wun T.C. Lipoprotein-associated coagulation inhibitor (LACI) is a cofactor for heparin: Synergistic anticoagulant action between LACI and sulfated polysaccharides. Blood 1992;79:430−8.
10. Bell W.R., Starksen N.F., Tong S., Porterfield J.K. Trousseau's syndrome. Devastating coagulopathy in the absence of heparin. Am J Med 1985;79:423−30.
Review
Views:
1305
Email this article 